-transparent.png){kind=logo}
A patient with renal failure due to myeloma kidney and coincident digitalis intoxication due to prescribed daily digoxin administration was treated with digoxin-specific antibody fragments and plasmapheresis. Rapid response to therapy was noted, removal of digoxin-antidigoxin antibody complexes was confirmed, and prevention of delayed rebound toxicity was documented. We suggest that this is the therapy of choice in similar individuals.
Related Publications
G M Rabetoy, and
C A Price, and
J W Findlay, and
J M Sailstad
January 1989,
Klinische Wochenschrift,
G M Rabetoy, and
C A Price, and
J W Findlay, and
J M Sailstad
October 1986,
Clinical pharmacy,
G M Rabetoy, and
C A Price, and
J W Findlay, and
J M Sailstad
September 1979,
Deutsche medizinische Wochenschrift (1946),
G M Rabetoy, and
C A Price, and
J W Findlay, and
J M Sailstad
July 1983,
The New England journal of medicine,
G M Rabetoy, and
C A Price, and
J W Findlay, and
J M Sailstad
October 1997,
Therapeutic drug monitoring,
G M Rabetoy, and
C A Price, and
J W Findlay, and
J M Sailstad
June 1988,
Critical care medicine,
G M Rabetoy, and
C A Price, and
J W Findlay, and
J M Sailstad
January 1984,
Acta cardiologica,
G M Rabetoy, and
C A Price, and
J W Findlay, and
J M Sailstad
January 2007,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
G M Rabetoy, and
C A Price, and
J W Findlay, and
J M Sailstad
May 1987,
Anaesthesia and intensive care,
G M Rabetoy, and
C A Price, and
J W Findlay, and
J M Sailstad
January 2013,
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria,
